Dr. Amir Inamdar is a qualified psychiatrist and pharmaceutical physician with 20+ years in clinical and drug development. He has successfully advanced numerous drugs through preclinical and early-phase trials to proof-of-concept studies. Dr. Inamdar leads global teams in developing medications for psychiatric conditions such as treatment-resistant depression, narcolepsy, anxiety, schizophrenia, bipolar disorder, and substance use disorders.